Frisco Holding II - 06 Feb 2026 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Reporting relationship: 10%+ Owner
Issuer ticker: HCA
Reported as of: 06 Feb 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 10 Feb 2026, 20:05:24 UTC
Source filing: View source filing
Reporting owner signature: /s/ J. William B. Morrow, President

Key filing fact

Frisco Holding II filed Form 4 for HCA Healthcare, Inc. (HCA) on 10 Feb 2026.

Key facts

This page summarizes Frisco Holding II's Form 4 filing for HCA Healthcare, Inc. (HCA).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 10 Feb 2026, 20:05.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001433317 Primary reporting owner

Frisco Holding II

Relationship: 10%+ Owner
Address: 3100 WEST END AVENUE, NASHVILLE
Signature: /s/ J. William B. Morrow, President
Signature date: 10 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HCA transaction

Common Stock, par value $0.01 per share

Other

Transaction value
Shares: -36,629,188
Change %: -100%
Price
Shares after: 0
Date: 06 Feb 2026
Ownership: Direct
Footnotes: F1, F2, F3

HCA transaction

Common Stock, par value $0.01 per share

Other

Transaction value
Shares: +36,557,141
Change %
Price
Shares after: 36,557,141
Date: 06 Feb 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

On February 6, 2026, the Reporting Person disposed of 36,629,188 shares of Common Stock, par value $0.01 per share ("Shares"), of HCA Healthcare, Inc. (the "Issuer"), in exchange for 36,557,141 Shares newly issued by the Issuer to the Reporting Person, in each case, in a transaction exempt from the registration requirements of the Securities Act of 1933 and from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3 thereunder. These transactions, together with the conversion of the Reporting Person to an entity taxable as a partnership for U.S. federal income tax purposes, constituted a reorganization for purposes of Section 368(a) of the Internal Revenue Code of 1986, as amended.

Footnote F2

The Reporting Person is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr.

Footnote F3

The Shares disposed of were previously reported by the Reporting Person as indirectly beneficially owned through Hercules Holding II ("Hercules"). Prior to the disposition reported in this filing, those shares were distributed for no consideration and on a pro rata basis by Hercules, effecting a change in form of beneficial ownership without changing the Reporting Person's pecuniary interest.